Your browser doesn't support javascript.
In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction.
Silva-Arrieta, Sandra; Goulder, Philip J R; Brander, Christian.
  • Silva-Arrieta S; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.
  • Goulder PJR; Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
  • Brander C; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
PLoS Pathog ; 16(6): e1008607, 2020 06.
Article in English | MEDLINE | ID: covidwho-687901

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Epitopes, T-Lymphocyte / Pandemics Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: PLoS Pathog Year: 2020 Document Type: Article Affiliation country: Journal.ppat.1008607

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Epitopes, T-Lymphocyte / Pandemics Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: PLoS Pathog Year: 2020 Document Type: Article Affiliation country: Journal.ppat.1008607